F2R and ovarian carcinoma: We previously identified significant overexpression of G protein-coupled receptors (GPCRs) in ovarian cancer tissues, including the protease-activated receptor 1 (PAR1), also known as coagulation factor II thrombin receptor (F2R) [3].